Andrew Lennard
Andrew Lennard is EFPIA Topic Lead Expert on the ICH Q1 revision EWG and member of the Global Regulatory Affairs CMC Team at Amgen.
JournalICH Q1 guideline revisions to promote innovation and enable global patient access to high-quality medicines
This article looks at the new ICH Q1 stability guidance and its various approaches to help promote innovation.